WHO ICTRP trial

The INJECT study - effect of a self-management intervention on needle fear in…

ACTRN12621000229875 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12621000229875
Public title The INJECT study - effect of a self-management intervention on needle fear in adults receiving haemodialysis.
Scientific title Improving Management of Needle Distress during the Journey to Dialysis through Psychological EduCation and Training – The INJECT study (feasibility pilot).
Primary sponsor Royal Adelaide Hospital
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions needle fear;haemodialysis patients; needle fear haemodialysis patients;Renal and Urogenital - Kidney disease
Interventions This pilot is a patient self-management intervention (INJECT) designed to empower patients to self-manage needle distress and to evaluate the feasibility and acceptability of the INJECT intervention. The intervention is based on Cognitive…
Registration date Apr 3, 2021
Target size 20
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations